CLINICAL_TRIALS
trial_result
· 2010-02-22
Clinical Trial Update: Efficacy and Safety Study of XP12B in Women With Menorrhagia [Phase 3]
Summary
Phase 3 efficacy and safety study results for XP12B in women with menorrhagia/heavy menstrual bleeding; results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Menorrhagia, Heavy Menstrual Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2010-02-22